CDKN2 mutations in melanoma.
Dracopoli
N C
NC
Sequana Therapeutics Inc., La Jolla, California 92037, USA.
Fountain
J W
JW
D002352:Carrier Proteins / Q000235:genetics*; D019941:Cyclin-Dependent Kinase Inhibitor p16; D018450:Disease Progression; D016147:Genes, Tumor Suppressor; D018740:Genetic Heterogeneity; D006579:Heterozygote; D006801:Humans; D008545:Melanoma / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D009154:Mutation; D010507:Periodicity; D012878:Skin Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy
D002352:Carrier Proteins; D019941:Cyclin-Dependent Kinase Inhibitor p16